GARLIC PREPARATIONS AND ANTIRETROVIRAL DRUGS

大蒜制剂和抗逆转录病毒药物

• 批准号: 6582651
• 负责人: DAVID J GREENBLATT
• 金额: $ 35.66万
• 依托单位: TUFTS UNIVERSITY BOSTON
• 依托单位国家: 美国
• 财政年份: 2002
• 资助国家: 美国
• 起止时间: 2002-09-15 至 2005-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6582651
• 关键词: AIDS therapy; HIV infections; P glycoprotein; SDS polyacrylamide gel electrophoresis; alternative medicine; angiosperms; antiAIDS agent; antiviral agents; biological products; blood chemistry; clearance rate; clinical research; combination therapy; cytochrome P450; drug interactions; drug metabolism; enzyme induction /repression; human subject; midazolam; pharmacokinetics; physical chemical interaction; protein isoforms; ritonavir; saquinavir; tissue /cell culture; western blottings

DESCRIPTION (provided by applicant): The use of complementary and alternative medical (CAM) therapies, including botanical medicines, is increasing continuously. Botanical medicines are of particular importance, since these natural preparations may cause clinically important drug interactions with prescription drugs, in particular the antiretroviral drugs that have become the principal medical treatment for individuals with HIV infection and AIDS. This population commonly uses additional CAM treatments, including botanical medicines. Garlic is commonly taken by patients with HIV, and garlic has been shown to interact with saquinavir. The broad objective of this project is to develop and test research models to enhance mechanistic understanding of interactions between botanicals and antiretrovirals, such that clinically important interactions can be anticipated and prevented. We propose a combined experimental and clinical approach to evaluating the influence of garlic, and of selected chemical components of garlic, on the processes regulating disposition of the majority of antiretroviral agents (metabolism by CYP3A and transport by P-glycoprotein), and on the pharmacokinetics of two representative antiretrovirals, ritonavir and saquinavir. There are two specific aims. The experimental component will assess the effect of two garlic preparations (standardized garlic and aged garlic extract), and several individual chemical components, in the following systems: inhibitory actions on human CYP3A (and other CYPs) in human liver microsomes; induction of CYP3A in primary human hepatocyte culture; inhibition of P-gp transport in Caco-2 transwell cultures; and induction of P-gp expression in LS180V transwell cell cultures. In clinical studies of healthy human volunteers, we will study the effect of 14 days of exposure to standardized garlic, aged garlic extract, and placebo on: the clearance of oral midazolam, a CYP3A probe substrate; the clearance of oral fexofenadine, a probe P-gp substrate; and the pharmacokinetics of ritonavir and saquinavir, representative antiretrovirals dependent on CYP3A and P-gp for disposition and clearance. Kinetics of these compounds are determined prior to, during, and after garlic exposure. The work will provide immediately applicable clinical data on garlic interactions with antiretrovirals, as well as mechanistic data identifying the interaction process and its predictability from in vitro models.

描述（由申请人提供）：补充和替代医学（CAM）疗法，包括植物药的使用正在不断增加。植物药特别重要，因为这些天然制剂可能与处方药，特别是抗逆转录病毒药物发生临床上重要的药物相互作用，而抗逆转录病毒药物已成为艾滋病毒感染和艾滋病患者的主要药物治疗。这一人群通常使用额外的CAM治疗，包括植物药。大蒜是艾滋病病毒感染者常用的药物，大蒜已被证明与沙奎那韦相互作用。该项目的广泛目标是开发和测试研究模型，以提高对植物药和抗逆转录病毒药物之间相互作用的机制理解，从而可以预测和预防临床上重要的相互作用。我们提出了一个综合的实验和临床方法来评估大蒜的影响，大蒜的化学成分，对大多数抗逆转录病毒药物（代谢的CYP 3A和运输的P-糖蛋白）的处置过程中的调节，并对两个代表性的抗逆转录病毒药物，利托那韦和沙奎那韦的药代动力学。有两个具体目标。实验部分将评估两种大蒜制剂的效果（标准化大蒜和老化大蒜提取物）和几种单独的化学成分，在以下系统中：对人CYP 3A的抑制作用（和其他CYP）;诱导原代人肝细胞培养物中的CYP 3A;抑制Caco-2 transwell培养物中的P-gp转运;和在LS 180 V transwell细胞培养物中诱导P-gp表达。在健康志愿者的临床研究中，我们将研究暴露于标准化大蒜、陈化大蒜提取物和安慰剂14天对以下方面的影响：口服咪达唑仑（一种CYP 3A探针底物）的清除率;口服非索非那定（一种探针P-gp底物）的清除率;利托那韦和沙奎那韦（依赖于CYP 3A和P-gp的分布和清除的代表性抗逆转录病毒药物）的药代动力学。这些化合物的动力学确定之前，期间和之后大蒜曝光。这项工作将提供大蒜与抗逆转录病毒药物相互作用的直接适用的临床数据，以及识别相互作用过程及其体外模型可预测性的机械数据。